Published in J Immunol on December 01, 1985
Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 4.31
Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med (1987) 3.53
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein. Proc Natl Acad Sci U S A (1988) 1.79
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78
In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol (1996) 1.39
Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med (1990) 1.30
Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy. J Exp Med (1993) 1.30
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol (2009) 1.21
Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. J Clin Invest (1989) 1.11
HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol (1988) 1.08
Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body. Immunology (1989) 1.08
Synovial biology and T cells in rheumatoid arthritis. Pathophysiology (2005) 1.05
Class II MHC antigens in the rat digestive system. Normal distribution and induced expression after interferon-gamma treatment in vivo. Immunology (1989) 1.02
Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology (1994) 1.01
Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med (1996) 1.00
Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion (2010) 0.98
Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin (2012) 0.97
Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology (1991) 0.96
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol (2010) 0.96
MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Immunology (1990) 0.95
A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol (2004) 0.93
Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Immunology (1997) 0.93
Endothelial cells present antigens in vivo. BMC Immunol (2004) 0.92
Renal allograft rejection: investigation of alloantigen presentation by cultured human renal epithelial cells. Immunology (1991) 0.91
Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells. J Exp Med (1992) 0.90
Cellular responses to human chondrocytes: absence of allogeneic responses in the presence of HLA-DR and ICAM-1. Clin Exp Immunol (1992) 0.89
Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. Immunology (1995) 0.88
Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. J Clin Invest (1990) 0.87
Interferon-gamma-dependent immunosuppressive effects of human gingival fibroblasts. Immunology (1992) 0.87
Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones. J Exp Med (1988) 0.84
Alteration of intestinal epithelial function by intraepithelial lymphocyte homing. J Gastroenterol (2005) 0.84
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
Are mesenchymal stromal cells immune cells? Arthritis Res Ther (2015) 0.83
MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. Cold Spring Harb Perspect Biol (2013) 0.83
Lipopolysaccharide augments HLA-A,B,C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultured human endothelial cells. Immunology (1991) 0.81
Antigen-presenting cell engineering. The molecular toolbox. Am J Pathol (1996) 0.81
Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line. Clin Exp Immunol (1989) 0.81
Antigen-presenting properties of gingival fibroblasts in chronic adult periodontitis. Clin Exp Immunol (1997) 0.81
Human osteoblast-like cells expressing MHC class II determinants stimulate allogeneic and autologous peripheral blood mononuclear cells and function as antigen-presenting cells. Immunology (1989) 0.80
Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect Immun (1999) 0.80
The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes. Immunology (1989) 0.79
Macrophage functions are regulated by the substratum of murine decidual stromal cells. J Clin Invest (1990) 0.78
Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis. Ann Rheum Dis (1991) 0.76
Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-γ Modified Mesenchymal Stem Cells. Stem Cells Int (2017) 0.75
HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia (2016) 0.75
HLA-DR antigen expression on the thyrocytes of Graves' disease patients. Korean J Intern Med (1988) 0.75
Immunoelectron microscopic analysis of Ia antigen expression in rat skin during limb allograft rejection. Am J Pathol (1990) 0.75
Induction of Ia antigens on synovial cells by gamma interferon. Korean J Intern Med (1987) 0.75
Cyclooxygenase in biology and disease. FASEB J (1998) 7.17
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem (1993) 3.57
Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol (1995) 3.31
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol (2001) 3.07
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol (2000) 3.05
Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol (1983) 3.04
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum (2004) 3.00
Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol (1991) 2.69
Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest (1997) 2.44
Macrophage-lymphocyte interaction. II. Antigen-mediated physical interactions between immune guinea pig lymph node lymphocytes and syngeneic macrophages. J Exp Med (1975) 2.44
Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells. J Immunol (1979) 2.36
Isolation and characterization of human peripheral blood dendritic cells. J Immunol (1993) 2.33
The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells. Immunol Today (1989) 2.31
The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum (1994) 2.26
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol (2000) 2.17
Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3. J Immunol (1987) 2.03
Macrophage-lymphocyte interaction. I. Characteristics of the antigen-independent-binding of guinea pig thymocytes and lymphocytes to syngeneic macrophages. J Exp Med (1973) 2.00
Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. J Immunol (1987) 1.97
Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay. J Immunol (1978) 1.93
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum (1988) 1.90
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (1996) 1.85
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol (1990) 1.83
Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol (1997) 1.80
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol (1985) 1.78
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol (1988) 1.71
Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J Exp Med (1989) 1.69
Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol (1994) 1.67
Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol (1988) 1.67
Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol (1987) 1.66
Spontaneous and induced membrane hyperpolarizations in macrophages. J Cell Physiol (1975) 1.64
Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1985) 1.63
Migration of naive and memory T cells. Immunol Today (1997) 1.62
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum (1990) 1.61
Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest (1996) 1.57
Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci U S A (1990) 1.56
A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci U S A (1994) 1.53
Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest (1997) 1.52
Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol (1990) 1.51
Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest (1998) 1.50
Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis (2005) 1.49
The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. J Immunol (1983) 1.49
Inhibitory influence of IL-4 on human B cell responsiveness. J Immunol (1988) 1.48
Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem (1993) 1.48
Infliximab in active early rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol (1986) 1.46
The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol (1995) 1.46
Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J Clin Invest (1998) 1.45
Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence. J Immunol (1976) 1.45
Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells. J Immunol (1985) 1.44
Macrophage-lymphocyte interaction and antigen recognition. Fed Proc (1975) 1.44
Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus (2004) 1.43
Relationship between clinical efficacy and laboratory correlates of inflammatory and immunologic activity in rheumatoid arthritis patients treated with nonsteroidal antiinflammatory drugs. Arthritis Rheum (1990) 1.43
Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol (1994) 1.43
Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum (1995) 1.42
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum (1994) 1.41
T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol (1988) 1.41
The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am (2000) 1.39
A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol (2001) 1.39
Accessory cell signals involved in T-cell activation. Immunol Rev (1990) 1.37
Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv Immunol (1987) 1.35
Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol (2000) 1.35
Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol (1998) 1.35
Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. J Immunol (1991) 1.34
Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med (1982) 1.34
Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.33
Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest (1997) 1.32
Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest (1981) 1.31
Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts. J Immunol (1987) 1.29
Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol (1990) 1.28
Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J Immunol (1991) 1.28
Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes. J Immunol (1986) 1.27
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol (1995) 1.27
The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum (1992) 1.25
Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes. J Immunol (1977) 1.25
Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol (1995) 1.25
Immunoglobulin secretion by human splenic lymphocytes in vitro: the effects of antibodies to IgM and IgD. J Immunol (1978) 1.24
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum (2000) 1.24
Phenotypic and functional characterization of human T cell clones. J Immunol (1988) 1.24
Interleukin 21 as a target of intervention in autoimmune disease. Ann Rheum Dis (2008) 1.23
The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation. Eur J Immunol (1986) 1.21
Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol (1998) 1.20
Immunoregulatory role of CD40 in human B cell differentiation. J Immunol (1993) 1.20
Raf-1 is required for T cell IL2 production. EMBO J (1993) 1.20
CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol (2000) 1.20
Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol (1995) 1.19
MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol (1996) 1.19
Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res (2001) 1.18
Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Immunol Today (1996) 1.18
Staphylococcal protein A, a T cell-regulated polyclonal activator of human B cells. J Immunol (1980) 1.18